TNF and cancer: In contrast, C0008 at the highest concentration resulted in a substantial release of TNFα, MCP-1, and IL6 from PBMCs without target cells (Fig. 4E–H) at levels 3- to 5-fold lower than in the presence of target cancer cells (Fig. 4A–D).